---
layout: post
title: "Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Multivalent Vaccines for Rabies Virus and Coronaviruses"
date: 2026-02-05 19:00:12 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-17214
original_published: 2022-08-11 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Multivalent Vaccines for Rabies Virus and Coronaviruses

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** August 11, 2022 00:00 UTC
**Document Number:** 2022-17214

## Summary

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Thomas Jefferson University, located in Philadelphia, Pennsylvania to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/08/11/2022-17214/prospective-grant-of-exclusive-license-inter-institutional-agreement-institution-lead-multivalent)
- API: https://www.federalregister.gov/api/v1/documents/2022-17214

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
